Screen Readers Skip to Content

Factors of ADHD Medication Use Study

Synopsis: Youth who take stimulant medication for ADHD early in life no more at risk for substance abuse in later adolescence than teens without ADHD.1

Author: University of Michigan Contact: umich.edu

Published: 2016-06-09

Main Digest

Youth who take Ritalin, Adderall or other stimulant medications for ADHD over an extended period of time early in life are no more at risk for substance abuse in later adolescence than teens without ADHD, according to a University of Michigan study.

The findings also show that teens who start using stimulant medications for attention deficit hyperactivity disorder for a short time later in adolescence - during middle or high school - are at high risk of substance use..

The U-M research is believed to be the first national study to compare early-use and longer-duration stimulant medication therapy with nonstimulant therapy for ADHD.

A large sample size of high school seniors also meant researchers could separate doctor-prescribed ADHD medication use by gender. The results show no gender differences in the overall associations between stimulant medication therapy for ADHD and risk of substance use, said Sean Esteban McCabe, a research professor at the U-M Institute for Research on Women and Gender.

More than 40,000 individuals from 10 cohorts nationwide between 2005 to 2014, answered questions about ADHD medication use and recent substance use as part of the Monitoring the Future study.

Among the findings:

Given that higher substance-use behaviors are associated with later initiation of stimulant medications for ADHD during adolescence, the researchers recommend monitoring this later initiation subgroup carefully for pre-existing risk factors or the onset of substance use behaviors.

McCabe collaborated with Kara Dickinson, former intern at the U-M Institute for Research on Women and Gender; Brady West, research associate professor at the U-M Institute for Social Research; and Dr. Timothy Wilens of Massachusetts General Hospital and Harvard University.

The findings appear in the current issue of the Journal of the American Academy of Child & Adolescent Psychiatry. The National Institute on Drug Abuse and National Institutes of Health supported research grants for the study.

Study: www.jaacap.com/article/S0890-8567(16)30099-5/abstract

Related Pharmaceutical Documents

Full List of Pharmaceutical Publications

Recent Disability News and Updates

Full List of Disabled World News Updates


Disclaimer: Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Please report outdated or inaccurate information to us.

Disclosure: Disabled World is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World. View our Advertising Policy for further information.

Cite Page: Journal: Disabled World. Language: English (U.S.). Author: University of Michigan. Electronic Publication Date: 2016-06-09. Title: Factors of ADHD Medication Use Study, Source: <a href=https://www.disabled-world.com/medical/pharmaceutical/adhd-meds.php>Factors of ADHD Medication Use Study</a>. Retrieved 2021-03-06, from https://www.disabled-world.com/medical/pharmaceutical/adhd-meds.php - Reference: DW#269-12235.